Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta

Archives of Disease in Childhood

Volumn 86, Issue 5, 2002, Pages 356-364

  Astrom E ^a   Soderhall S ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANALGESIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN TYPE 1 CARBOXY TERMINAL PEPTIDE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BONE DENSITY; BONE METABOLISM; CARBOXY TERMINAL SEQUENCE; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; INFANT; LOCOMOTION; LUMBAR SPINE; MALE; OBSERVATION; OSTEOGENESIS IMPERFECTA; PAIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; SPINAL CORD COMPRESSION; SPINE FRACTURE; TREATMENT OUTCOME; WELLBEING;

ADOLESCENT; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; CHILD; CHILD, PRESCHOOL; DENSITOMETRY, X-RAY; DIPHOSPHONATES; FRACTURES, SPONTANEOUS; HEALTH STATUS; HUMANS; INFANT; INFUSIONS, INTRAVENOUS; LONG-TERM CARE; OSTEOGENESIS IMPERFECTA; PAIN; PROSPECTIVE STUDIES; RECURRENCE; SPINAL CORD COMPRESSION; TREATMENT OUTCOME;

EID: 0036250837     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.86.5.356     Document Type: Article

References (36)

1. Clinical variability in osteogenesis imperfecta. Variable expressivity or genetic heterogeneity
2. Genetic heterogeneity in osteogenesis imperfecta
3. Mutations in type 1 procollagen that cause osteogenesis imperfecta. Effects of the mutations on the assembly of collagen into fibrils, the basis of phenotypic variations and potential antisense therapies
4. Fluoride therapy in metabolic bone disease
5. Just taller or more bone? The impact of growth hormone on osteogenesis imperfecta and idiopathic juvenile osteoporosis
6. Therapy of osteogenesis imperfecta with synthetic salmon calcitonin
7. Effect of long-term calcitonin therapy by injections and nasal spray on the incidence of fractures in osteogenesis imperfecta
8. Two models of action of bisphosphonates on osteoclastic resorption of mineralized matrix
9. Bisphosphonates
10. Bisphosphonates: From grandparents to grandchildren
11. Maintained improvement in calcium balance and bone mineral content in patients with osteoporosis treated with the bisphosphonate APD
12. Long-term effects of dichloromethylene diphosphonate in patients with osteolytic bone metastases and coincident primary hyperparathyroidism
13. Regression of bone lesions in Gaucher's disease during treatment with aminohydroxypropylidene bisphosphonate
14. Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta
15. Is APD a promising drug in the treatment of severe osteogenesis imperfecta?
16. Cyclic administration of pamidronate in children with severe osteogenesis imperfecta
17. Beneficial effect of bisphosphonate during five years of treatment of severe osteogenesis imperfecta
18. Total body bone mineral and lean body mass by dual-photon absorptiometry. I. Theory and measurement procedure
19. Dual-energy x-ray absorptiometry in normal women: A cross-sectional study of 717 Finnish volunteers
20. Nonoperative treatment of osteogenesis imperfecta: Orthotic and mobility management
21. Bone mineral content and density in healthy subjects and in osteogenesis imperfecta
22. Intravenous pamidronate treatment in osteogenesis imperfecta
23. Bisphosphonates in osteogenesis imperfecta
24. Hypercalcemia in osteogenesis imperfecta treated with pamidronate
25. Intravenous pamidronate treatment in osteogenesis imperfecta
26. Bisphosphonates in children with osteogenesis imperfecta may improve bone mineralization but not bone strength. Report of two patients
27. Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age
28. Treatment of osteogenesis imperfecta with the bisphosphonate olpandronate (dimethylaminohydroxypropylidene bisphosphonate)
29. Osteogenesis imperfecta: Mosaicism and refinement of the genotype-phenotype map in Ol type III. Mut in brief 242
30. Osteogenesis imperfecta: A clinical study of the first ten tears of life
31. Osteogenesis imperfecta in childhood and adolescence
32. Osteogenesis imperfecta in childhood: Impairment and disability - A follow up study
33. Hypercalciuria in children severely affected with osteogenesis imperfecta
34. Vital biomechanics: Proposed general concepts for skeletal adaptations to mechanical usage